wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q44669628-A63BD9A9-992C-4D45-90A0-69B0F53DA395
Q44669628-A63BD9A9-992C-4D45-90A0-69B0F53DA395
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44669628-A63BD9A9-992C-4D45-90A0-69B0F53DA395
Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer.
P2860
Q44669628-A63BD9A9-992C-4D45-90A0-69B0F53DA395
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44669628-A63BD9A9-992C-4D45-90A0-69B0F53DA395
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b2261ab6f35aaaee3bbaa1370a10012b47c20237
P2860
A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epi